The brain imaging and neuroimaging market is expected to reach approximately USD 15.1 billion in 2025 and expand to around USD 24.8 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.1% over the forecast period.
The brain imaging and neuroimaging market is seeing an impressive boom due to accelerating technological growth coupled with rising rates of neurologic diseases among the population and skyrocketing demands for early and precise diagnosis of these diseases. Advances in MRI, CT, PET, and functional imaging are transforming the detection, monitoring, and treatment of brain-related diseases. AI-aided imaging, high-resolution spiral scanning, and open horizons in neuroscience and personalized medicine are driving the market high enough.
Expansion in governmental and private investments in healthcare facilities along with an aspiration for minimally invasive diagnosis gives this impetus. With rising cases of Alzheimer, Parkinson, epilepsy, and of brain tumors, it further increases the need for advanced neuroimaging solutions. The emerging trends are portable imaging machines, brain mapping in real time, and hybrid imaging technology that makes scanning the brain faster, more precise, and affordable than ever before, thus designing the future of neuroimaging.
Market Metrics
| Metric | Value |
|---|---|
| Industry Size (2025E) | USD 15.1 billion |
| Industry Value (2035F) | USD 24.8 billion |
| CAGR (2025 to 2035) | 5.1% |
With the conventional structural imaging giving way to functional imaging technologies like fMRI and PET since 2020, it has been possible to analyze brain activity more accurately with better imaging. AI-driven diagnostics that improve imaging accuracy further aid in early diagnosis and disease monitoring.
Additionally, aside from clinical diagnostics, neuroimaging applications have expanded to mental health studies, cognitive research, and pharmaceutical drug development, further increasing the overall market potential. The market has considered PET-MRI and PET-CT hybrid imaging technology in the recent years because it offers improved confidences into complex neurological conditions.
Over the past few years, wearable and portable brain imaging technologies have picked up speed within the market, thus making neuroimaging theoretically feasible for point-of-care and remote applications.
Ongoing funding by governments and private organizations in neurology-specific research and development has raised the level of innovation attention on Alzheimer's, Parkinson's, and stroke diagnosis, due to the aforementioned reasons. All these contribute to expanding the market for neuroimaging solutions, paving the way for smarter, faster, and more accessible neuroimaging solutions.
Explore FMI!
Book a free demo
Adoption of medical technologies, strong healthcare infrastructure, and extensive deployment of advanced imaging solutions make North America the leading neuroimaging and brain imaging market. Dominant players in conjunction with prime-level research institutes in the continent drive further development of AI neuroimaging for enhanced diagnosis efficacy and accuracy.
The increase in prevalence of neurological disorders and the elderly population drive continuous growing demand for new brain imaging solutions specifically targeting Alzheimer's, multiple sclerosis, and TBI. Government subsidies and private support of investments in neuroscience research remain driving forces behind market growth.
The NIH and FDA are important to enable developments, with the supportive reimbursement scheme permitting new technologies to thrive. North America still leads in precision neurology care and medicine, leading the way for more focused treatments.
Brain and neuroimaging is among the primary markets in Europe due to efficient healthcare infrastructure, growing research collaboration, and several government-initiated healthcare programs. The primary countries utilizing hybrid imaging from Europe are Germany, the United Kingdom, and France, as the technologies provide enhanced diagnostic ability for complicated neurological disorders. Demand for high-resolution brain imaging solutions is perpetually being driven by the expectation of early diagnosis and preventive neurology.
Active support provided to neuroscience research and AI-attributed integration by the European Union in medical imaging gives rise to new products as well as better healthcare practices. A strict regulation around radiation exposure regarding patient safety would highly affect the application of non-invasive and radiation-free brain imaging methods. Further opportunities in the development of telemedicine and cross-border healthcare partnerships therefore guarantee technological progress in the continent.
The Asia region's consistent expanding market of brain imaging and neuroimaging is attributed to increasing healthcare investments, enhanced medical infrastructure, and increasing burdens of neurocommunity. The need for advanced neuroimaging is on the rise in China, Japan, and India because of patient awareness and increasing disposable incomes.
Public-sector initiatives are accelerating healthcare access, especially in rural and emerging regions of the nations, accelerating adoption for affordable imaging technology. Thailand, South Korea, and Singapore's medical tourism will stimulate investments in advanced neuroimaging facilities while AI and cloud-based imaging platforms are transforming diagnosis, enabling brain imaging to be more scalable and efficient.
With continued developments in technology and increased emphasis on neurological studies and education, Asia is also bound to emerge as a major hotbed of neuroimaging technologies.
Challenges
Regulatory Hurdles Slowing Technological Adoption Are a Major Restraining Factor
Regulatory challenges pose a significant constraint to the commercialization of emerging imaging technologies and the diffusion of the same into the market. The lengthy adjudication time in obtaining those second approvals from FDA, EMA, and other global regulatory authorities lead to longer product development timelines, higher compliance costs, and slower market introductions, all detrimental to the innovative development of those products.
It not only affects the manufacturers but also hinders healthcare providers from accessing new and advanced neuroimaging developments, also influencing the overall growth of the market.The existence of varying regulations across regions adds to barriers for companies wishing to expand their domains internationally.
Although regulations are needed for patient safety and device effectiveness, their elaborative and time- consuming nature frustrates technological progress. Fast-track approval processes with a harmonized international standard and close collaboration between regulators and industry will be therefore vital in solving these challenges to accelerate innovation and improve access without compromising safety.
Opportunities
Rising Demand for Portable and Wearable Imaging Devices Is a Key Market Opportunity
There has been increasing demand for portable and wearable imaging technology, which is a big growth-driving market force because it makes diagnostic access convenient and efficient. Traditional neuroimaging machines like MRI and PET scanners are relatively costly, and in most cases, only well-equipped institutions have access to them.
With the advances of modern miniaturization technology, wireless communication, and artificial intelligence-aided imaging, creation of tiny mobile imaging systems can be brought about to be utilized in home care, in emergency rooms, or in rural clinics.
This transition is decreasing reliance on heavy hospital infrastructure, making it easier and less expensive to obtain brain images. Further, increased investment in telemedicine and precision medicine is fuelling the demand for wearable technology for ongoing brain activity monitoring, stroke detection early in its stages, and monitoring of mental status.
With the focus of healthcare systems on distant diagnostics and point-of-care medicine, the increase in demand for portable neuroimaging technologies is likely to result in significant market growth in the near future.
Trends
AI-Powered Image Analysis Enhancing Diagnostic Accuracy
The integration of AI-powered image analysis is one of the main drivers of this market to ensure better accuracy and efficiency in diagnosis. AI algorithms can catch nuances of anomalies in the brain more quickly than any other traditional method, thus speeding up the process of diagnosis to allow better and faster detection of brain-related diseases.
This will be of great use in cases such as that of Alzheimer’s, stroke, and certain tumors, where early detection is of utmost importance. Moreover, AI-powered automation will help fill the gap that a lack of skilled radiologists in the workforce has created. This, therefore, will work towards easing workflow pressures and melting away human error. With further advancement in AI technologies, the implantation of AI in the area of real-time brain imaging and predictive analytics is expected to add impetus to the market growth.
Growing Adoption of Hybrid Imaging Technologies
The market is also seeing one more important trend in the growth of hybrid imaging solutions, including systems such as PET-MRI and PET-CT. These use combinations of imaging technologies, giving them outstanding diagnostic capabilities among complex neurological cases.
States such as these allow better disease characterization that leads to improved patient outcomes and even enhanced uses in the research arena. Advances in imaging software and hardware technology keep supporting multi-modal imaging lately, which rapidly shapes into the becoming standard in diagnostics in neurology, adding fire to its demand.
The last decade has seen the market experience dynamic evolution with the evolution in imaging resolution, rapid scan time, and increased application of multimodal imaging methods. As the need for early and precise diagnosis of neurological diseases increases, high-field MRI, diffusion tensor imaging, and functional neuroimaging are in huge demand. Neurology-focused research studies and clinical trials for such conditions as stroke, epilepsy, and neurodegenerative diseases help to fuel the growing demand for such sophisticated imaging solutions.
A steady blend in the form of smooth technology upgradations reflects more investment in healthcare and, rising patient awareness shall provide the market with continuous expansion. Firstly, the shift towards economical imaging solutions and the ease of availability in developing economies shall be a significant fillip to the extensive acceptance of the market.
Increased development of newer technology in the context of the non-invasive and radiation-free imaging method will drive large acceptability from larger populace developing safer and much more precise neurological assessments.
Market Shifts: A Comparative Analysis (2020 to 2024 vs. 2025 to 2035)
| Market Shift | 2020 to 2024 |
|---|---|
| Regulatory Landscape | Regulatory authorities are adopting regulations to maintain the safety and efficacy of brain imaging systems, formulating standardized protocols and use regulations. |
| Technological Advancements | Introduction of instruments capable of capturing high-resolution images of the brain, facilitating comprehensive assessments and early diagnosis. |
| Consumer Demand | Care givers and patients are more often embracing advanced image solutions, inducing greater demand for different healthcare outlets, especially to detect neurological disease at early stages. |
| Market Growth Drivers | The rising prevalence of neurological diseases is propelling growth, plus new enhancements in medical imaging technology and the shift towards a cost-benefit ratio in line with efficient diagnostics. |
| Sustainability | Companies are launching green processes and creating environmentally friendly imaging systems. |
| Supply Chain Dynamics | Dependence on specialized suppliers for device components, with efforts to localize production to mitigate supply chain disruptions observed during global events. |
| Market Shift | 2025 to 2035 |
|---|---|
| Regulatory Landscape | Regulators constantly track and amend regulations to strike a balance between patient safety and technology innovation, imposing stricter quality tests to ensure product efficacy. |
| Technological Advancements | Development of next-generation imaging systems with improved portability, user-friendly interfaces, and integration with artificial intelligence for enhanced diagnostic accuracy and personalized patient care. |
| Consumer Demand | Customers prefer patient-centered image systems and treatments, driven by enhanced image solutions and an even greater emphasis on early detection as well as on preventive medicine. |
| Market Growth Drivers | Growing healthcare infrastructure in developing regions is creating new dynamics with increasing healthcare expenditures in countries across the board, continuous technological advancement increasing procedural efficiency and improving general patient outcomes. |
| Sustainability | Organizations are embracing green practices in production and distribution, using recyclable material and energy-saving processes to meet international environmental regulations. Supply Chain Dynamics |
| Supply Chain Dynamics | Strengthening of local manufacturing capabilities through technological advancements and strategic partnerships, leading to reduced dependency on imports and improved supply chain resilience. |
Market Outlook
The USA neuroimaging and brain imaging market is increasing primarily due to the extremely high incidence of neurological disorders and strong emphasis on early intervention and diagnosis. MRI or positron emission tomography functions have been incorporated into the diagnostic process by clinicians, in order to possess high diagnostic accuracy and enhance prognostication. The large investments in R&D and a robust healthcare infrastructure base are factors that drive the growth of the market.
Market Growth Factors
Market Forecast
| Country | CAGR (2025 to 2035) |
|---|---|
| United States | 4.2% |
Market Outlook
Because of investments made to enhance health infrastructure in India, the brain imaging and neuroimaging market has been growing. The rising burden of neurological diseases is responsible for the ever-growing demand for holistic imaging solutions for their earlier detection and management. The government is increasing access and affordability of care, in fact, enabling further adoption of advanced imaging technology.
Market Growth Factors
Market Forecast
| Country | CAGR (2025 to 2035) |
|---|---|
| India | 6.1% |
Market Outlook
China's neuroimaging and brain imaging market is growing at a very high rate due to the changes in medical technology and investment in infrastructure. The increase in the burden of neurological disorders has boosted demand for sophisticated imaging solutions for better management of the diseases. Strengthened healthcare services by the government, along with a rising middle-class population that expects higher-quality medical services, are promoting growth.
Market Growth Factors
Market Forecast
| Country | CAGR (2025 to 2035) |
|---|---|
| China | 5.9% |
Market Outlook
The brain imaging and neuroimaging market of Germany has expanded, supported by the country's priority for health care innovations and steadfast high standards of medical care. The advanced imaging technologies are now progressively incorporated into the diagnostics of medical care by the healthcare institutions that contribute to increasing the growth rate in the CT, MRI, PET, and nuclear imaging modalities. Structure health systems, along with an increase in awareness of the neurological health of the society, will further support the growth of this market.
Market Growth Factors
Market Forecast
| Country | CAGR (2025 to 2035) |
|---|---|
| Germany | 3.8% |
Market Outlook
The Brazil market for brain-intensive imaging and neuroimaging is advancing with a strong focus on getting sophisticated technologically and precision diagnostics. Advanced imaging technologies are endorsed in the healthcare sector for early disease detection and effective management of neurological conditions. As this country has an older population, the ratio of people of 60 years and older is rising, which is increasing calls for complete neuroimaging services.
Market Growth Factors
Market Forecast
| Country | CAGR (2025 to 2035) |
|---|---|
| Brazil | 3.3% |
MRI Leading Brain Imaging with High Precision, Safety, and Versatility
MRI continues to lead the way in the brain imaging and neuroimaging industry due to its uncompromised accuracy as a non-invasive technique ensuring complete detail for soft tissue. Unlike CT or X-ray, MRI uses no ionizing radiation; therefore, it poses no threat to such patients who often get repeated scanning, in whom the condition is likely chronic like in neurological disorders.
The great contrast resolution helps the medical profession, through MRI, to make a very early and accurate diagnosis of Alzheimer's disease, MS, brain tumors, or stroke. The abilities of fMRI enable real-time brain function mapping for research and treatment planning.
The latest advances in high-field and ultra-high-field MRI have fine-tuned the image and the accuracy percentage of the diagnosis, hence making it the first choice for clinical and research applications alike. Adding AI-based analysis to MRI is further boosting efficiency in clinical operations, hence solidly cementing MRI as today's neuroimaging technology of first choice.
PET Emerging as a Game-Changer in Brain Imaging with Early Disease Detection
PET is developing into a widely used imaging modality specific for the brain and neuroimaging because a disease in the brain is diagnosed much earlier. Compared to MRI and CT, which take basic structural images of the space, PET takes functional images and can quantify metabolic activity, cerebral blood flow, and neurotransmitter function.
This ability enables healthcare professionals to identify such conditions as Alzheimer's, Parkinson's, epilepsy, and brain tumors when structural damage has yet to occur. The coupling of PET with CT and MRI in hybrid imaging devices improves the diagnostic accuracy through a combination of anatomical and functional information.
Scientists have created sophisticated radiotracers that enhance PET's precision in detecting abnormal protein accumulations, like amyloid plaques in Alzheimer's patients, to treat them earlier and more accurately. PET will transform personalized neurology and precision medicine as AI-based image analysis and novel tracers evolve further.
Neurodegenerative Diseases Leading Brain Imaging Applications with Rising Cases and Early Diagnosis Needs
Neurodegenerative diseases lead the brain imaging and neuroimaging market since occurrences of Alzheimer's, Parkinson's, Huntington's, and multiple sclerosis increase continuously. Because these conditions advance slowly and usually exhibit signs only in late stages, medical practitioners focus on timely and precise diagnosis to ensure proper control and treatment.
The experts use sophisticated imaging methods like MRI, PET, and functional imaging to identify fine brain changes, monitor disease course, and determine treatment outcomes. PET scans, for instance, enable experts to detect amyloid and tau protein accumulation in patients with Alzheimer's years before there are cognitive manifestations.
The expansion in the geriatric population and spending on neurology research in the healthcare sector is driving the demand for high-resolution imaging solutions. As biomarker-based diagnosis and AI-driven analytics grow more popular, neuroimaging continues to understand and treat neurodegenerative diseases even better.
Stroke and Traumatic Brain Injury (TBI) Emerging as Critical Applications in Brain Imaging
Stroke and TBI are now becoming a major area of interest for brain imaging, particularly given that they are high-incidence conditions requiring urgent diagnosis. These disorders are among the top reasons for disability and death globally and hence pose demands for advanced imaging solutions so that early effective treatment may be explored.
In stroke diagnoses performed by radiologists and neurologists, MRI and CT scans entail retrograde identification of ischemic and hemorrhagic strokes, evaluation of tissue injury, and suggestion of potential treatment options, such as thrombolysis. In traumatic brain injury, imaging assists in the detection of brain hemorrhages, edema, and structural damage to enable recovery monitoring and long-term damage evaluation.
Functional imaging methods such as PET and fMRI are also casting more light on the diagnosis by assessing brain activity, cognitive performance, and metabolic alterations in a modelling study to enhance the ultimate result prediction. With AI-supported imaging and innovative portable devices for brain scanning, the effective diagnosis and management of stroke and TBI are enhancing daily survivorship and final health outcomes.
The brain imaging & neuroimaging market is highly competitive due to the rising incidence of neurological disorders, advances in imaging technologies, and the growing uptake of AI-fueled diagnostic tools.
Companies are investing in high-resolution MRI, PET, and CT imaging systems, along with other functional neuroimaging solutions so as to secure a great competitive edge in the market. Well-established medical imaging manufacturers, neuroscience research firms, and now emerging digital health companies shape the market, each contributing in their own regard to the evolving landscape of neuroimaging solutions.
Market Share Analysis by Company
| Company Name | Estimated Market Share (%) |
|---|---|
| GE Healthcare | 22-26% |
| Siemens Healthineers | 18-22% |
| Philips Healthcare | 10-14% |
| Canon Medical Systems | 8-12% |
| Medtronic plc | 5-9% |
| Other Companies (combined) | 25-35% |
| Company Name | Key Offerings/Activities |
|---|---|
| GE Healthcare | Market leader offering high-resolution MRI and PET imaging systems for neuroimaging applications. |
| Siemens Healthineers | Develops AI-integrated brain imaging solutions for early diagnosis of neurological disorders. |
| Philips Healthcare | Specializes in functional neuroimaging tools, including advanced fMRI and CT scanning technologies. |
| Canon Medical Systems | Provides high-precision neuroimaging solutions with ultra-high field MRI and PET-CT systems. |
| Medtronic plc | Focuses on imaging-guided neurological interventions and deep brain stimulation technologies. |
Key Company Insights
GE Healthcare (22-26%)
Market leader in neuroimaging, GE Healthcare offers top-of-the-line high-resolution brain imaging technology ideal for accurate diagnosis and research use.
Siemens Healthineers (18-22%)
Market leader in medical imaging, Siemens offers advanced MRI and PET scanner-based diagnostic platforms supported by AI-empowered diagnostic capabilities.
Philips Healthcare (10-14%)
One of the most important functional neuroimaging innovators, Philips offers state-of-the-art fMRI and molecular imaging options for brain research.
Canon Medical Systems (8-12%)
One of the leading high-field MRI players, Canon excels in ultra-high-resolution imaging of the brain for clinical and research applications.
Medtronic plc (5-9%)
A leading supplier of neurology solutions, Medtronic combines imaging with brain stimulation technologies for therapy.
Other Key Players
Beyond the leading companies, several other manufacturers contribute significantly to the market, enhancing product diversity and technological advancements.
The overall market size for brain imaging and neuroimaging market was USD 15.1 billion in 2025.
The brain imaging and neuroimaging market is expected to reach USD 24.8 billion in 2035.
The increasing incidence of head trauma among athletes and military personnel is driving the demand for advanced neuroimaging solutions.
The top key players that drives the development of brain imaging and neuroimaging market are GE Healthcare, Siemens Healthineers, Philips Healthcare, Canon Medical Systems and Medtronic plc.
Magnetic resonance imaging (MRI) is expected to command significant share over the assessment period.
Magnetic Resonance Imaging (MRI), Computerized tomography (CT), Positron Emission Tomography (PET), Electroencephalography (EEG), Magnetoencephalography (MEG), Single Photon Emission Computed Tomography (SPECT), Functional near-infrared spectroscopy (fNIRS)
Stroke and Traumatic Brain Injury (TBI), Multiple Sclerosis, Brain Tumors, Epilepsy, Neurodegenerative disease (Alzheimer's Disease and Parkinson's Disease), Psychiatric disorders
Hospitals, Diagnostic Imaging Centers, Specialty Clinics, Academic and Research Institutes, Medical Imaging CRO
North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia & Pacific, Middle East & Africa
Gastro-retentive Drug Delivery Systems Market - Trends & Demand 2025 to 2035
Head and Neck Cancer (HNC) Therapeutics Market - Growth & Drug Developments 2025 to 2035
Healthcare Biometrics Market Trends - Growth, Demand & Forecast 2025 to 2035
Healthcare API Market Growth – Trends & Forecast 2025 to 2035
Glaucoma Treatment Market Overview – Trends & Forecast 2025 to 2035
Gastrointestinal Stent Market Growth – Trends & Forecast 2025 to 2035
Brain Imaging And Neuroimaging Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
